Physician profile
Utpalkumar Patel
NPI 1003077652
$5,575.71
in general payments reported to CMS, 2019-2025
34 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $190 · 2021: $598 · 2022: $845 · 2023: $1,125 · 2024: $1,207 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,946 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,945.59 |
| Education | $192.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $761.42 | 2019-2025 | |
| Janssen Biotech, INC. | $657.36 | 2019-2025 | Tremfya |
| Amgen INC. | $608.25 | 2020-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $434.81 | 2021-2025 | Ilumya, Odomzo, Blu-U |
| Novartis Pharmaceuticals Corporation | $430.40 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $362.93 | 2022-2024 | Sotyktu |
| Genzyme Corporation | $331.87 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $283.61 | 2020-2025 | Libtayo |
| Almirall LLC | $199.22 | 2019-2022 | |
| Dermavant Sciences, INC. | $199.10 | 2023-2024 | Vtama |
| Celgene Corporation | $177.91 | 2019 | |
| Leo Pharma INC. | $152.33 | 2023-2025 | Adbry |
| Lilly USA, LLC | $118.63 | 2019-2024 | Taltz |
| Pfizer INC. | $97.78 | 2023-2024 | |
| Strata Skin Sciences, INC. | $78.29 | 2019-2022 |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Utpalkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.